Free tool
Dividend paying stocks
We cover 91 companies that currently pay a dividend. The median market value in the group is $10.89B. Across the group, the median move over the past trading day is +0.79%. 61% of the 88 with a 200-day average trade above it. Price change over the past year runs from −22.3% to +60.1% across the middle 80 percent of the group, with a median of +2.0%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
91 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% | Oct 29, 2026 |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% | Oct 29, 2026 |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% | Oct 30, 2026 |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% | Nov 3, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% | Oct 21, 2026 |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% | Nov 4, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% | Nov 4, 2026 |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% | Oct 14, 2026 |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% | Oct 29, 2026 |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% | Nov 3, 2026 |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% | Oct 20, 2026 |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% | Oct 29, 2026 |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% | Oct 29, 2026 |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% | Oct 30, 2026 |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% | Oct 30, 2026 |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% | Oct 28, 2026 |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% | Oct 28, 2026 |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% | Oct 21, 2026 |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% | Oct 28, 2026 |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% | Nov 5, 2026 |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% | Nov 3, 2026 |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% | Nov 3, 2026 |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% | Nov 5, 2026 |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% | Nov 10, 2026 |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% | Nov 3, 2026 |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% | Nov 4, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% | Oct 22, 2026 |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% | Nov 5, 2026 |
| QS51.DE | Straumann Holding AG | $18.40B | Large cap | −1.10% | Oct 28, 2026 |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% | Nov 3, 2026 |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% | Nov 3, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% | Oct 22, 2026 |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% | Oct 28, 2026 |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% | Nov 3, 2026 |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% | Nov 10, 2026 |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% | Nov 12, 2026 |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% | Nov 4, 2026 |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% | Nov 17, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% | Nov 11, 2026 |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% | Nov 11, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% | Nov 12, 2026 |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% | Nov 4, 2026 |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% | Sep 17, 2026 |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% | Nov 4, 2026 |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% | Oct 29, 2026 |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% | Nov 12, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% | Nov 6, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% | Sep 10, 2026 |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% | Oct 29, 2026 |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% | Nov 4, 2026 |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% | Oct 22, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% | Nov 5, 2026 |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.31% | Oct 21, 2026 |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% | Sep 11, 2026 |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% | Nov 12, 2026 |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% | Nov 12, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% | Oct 21, 2026 |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% | Nov 5, 2026 |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% | Oct 22, 2026 |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% | Nov 3, 2026 |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% | Oct 23, 2026 |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% | Sep 8, 2026 |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% | Sep 29, 2026 |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% | Oct 22, 2026 |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% | Nov 12, 2026 |
| PIHLIS.HE | Pihlajalinna Oyj | $283.18M | Small cap | −28.38% | Oct 28, 2026 |
| ORIOLA.HE | Oriola Oyj | $195.27M | Small cap | −21.98% | Oct 29, 2026 |
| VISTN.OL | Vistin Pharma ASA | $91.60M | Micro cap | −15.42% | Oct 29, 2026 |
| ALC.SW | Alcon Inc. | — | — | −7.46% | Nov 10, 2026 |
| BION.SW | BB Biotech AG | — | — | +84.12% | Oct 23, 2026 |
| MOVE.SW | Medacta Group SA | — | — | −10.60% | Sep 9, 2026 |
| NOVN.SW | Novartis AG | — | — | +30.24% | Oct 27, 2026 |
| SOON.SW | Sonova Holding AG | — | — | +6.01% | Nov 12, 2026 |
| STMN.SW | Straumann Holding AG | — | — | −2.20% | Oct 28, 2026 |
| YPSN.SW | Ypsomed Holding AG | — | — | +4.01% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.